Akt Cancer Research Results
Akt, PKB-Protein kinase B: Click to Expand ⟱
| Source: HalifaxProj(inhibit) |
| Type: |
Akt1 is involved in cellular survival pathways, by inhibiting apoptotic processes; Akt2 is an important signaling molecule in the insulin signaling pathway. It is required to induce glucose transport.
Inhibitors:
-Curcumin: downregulate AKT phosphorylation and signaling.
-Resveratrol
-Quercetin: inhibit the PI3K/AKT pathway.
-Epigallocatechin Gallate (EGCG)
-Luteolin and Apigenin: inhibit AKT phosphorylation
|
Scientific Papers found: Click to Expand⟱
NF-kB↝, Akt↝, AR↝, Apoptosis↝, Bcl-2↝, Casp3↝, BAX↝, P21↝, ROS↝, Bcl-xL↝, JNK↝, MMP2↝, P53↝, PSA↝, VEGF↝, COX2/PTGS2↝, cycD1/CCND1↝, EGFR↝, IL6↝, β-catenin/ZEB1↝, mTOR↝, NRF2↝, AP-1↝, Cyt‑c↝, PI3K↝, PTEN↝, Cyc↝, TNF-α↝,
| - |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
CRC, |
HT-29 |
|
|
|
- |
in-vitro, |
Lung, |
A549 |
|
|
|
ChemoSen↑, TumCP↓, chemoP↑, *ROS↓, *mtDam↓, *Apoptosis↓, *cardioP↑, *NRF2↑, *TGF-β↑, *p‑JNK↓, *p‑p38↓, *MAPK↝, *Akt↝, *STAT3↝,
*antiOx↑, Keap1↝, NF-kB↝, NRF2↝, PI3K↝, Akt↝, mTOR↝, *GutMicro↑,
*MAPK↝, *AMPK↝, *NF-kB↓, *mTOR↝, *PI3K↝, *Akt↝, *BioAv↝, *memory↑, *BDNF↑, *TNF-α↓,
*ROS↓, *12LOX↓, *NF-kB↓, *BMD↑, *hepatoP↑, cycD1/CCND1↓, PKCδ↓, STAT3↓, ERK↑, MAPK↓, ROS↑, PI3K↝, Akt↝, Hif1a↝, *neuroP↑,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
Keap1↝, 1, NRF2↝, 2, ROS↑, 1, ROS↝, 1,
Cell Death(tgid=5) ⓘ
Akt↝, 3, Apoptosis↝, 1, BAX↝, 1, Bcl-2↝, 1, Bcl-xL↝, 1, Casp3↝, 1, Cyt‑c↝, 1, JNK↝, 1, MAPK↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↝, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
Cyc↝, 1, cycD1/CCND1↓, 1, cycD1/CCND1↝, 1, P21↝, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
ERK↑, 1, mTOR↝, 2, PI3K↝, 3, PTEN↝, 1, STAT3↓, 1,
Migration(tgid=13) ⓘ
AP-1↝, 1, MMP2↝, 1, PKCδ↓, 1, TumCP↓, 1, β-catenin/ZEB1↝, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
EGFR↝, 1, Hif1a↝, 1, VEGF↝, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
COX2/PTGS2↝, 1, IL6↝, 1, NF-kB↝, 2, PSA↝, 1, TNF-α↝, 1,
Hormonal & Nuclear Receptors(tgid=20) ⓘ
AR↝, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
AR↝, 1, EGFR↝, 1, IL6↝, 1, PSA↝, 1,
Functional Outcomes(tgid=23) ⓘ
chemoP↑, 1,
Total Targets: 43
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 1, NRF2↑, 1, ROS↓, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
mtDam↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
12LOX↓, 1, AMPK↝, 1,
Cell Death(tgid=5) ⓘ
Akt↝, 2, Apoptosis↓, 1, p‑JNK↓, 1, MAPK↝, 2, p‑p38↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
mTOR↝, 1, PI3K↝, 1, STAT3↝, 1,
Migration(tgid=13) ⓘ
TGF-β↑, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
NF-kB↓, 2, TNF-α↓, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
BDNF↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↝, 1,
Clinical Biomarkers(tgid=22) ⓘ
BMD↑, 1, GutMicro↑, 1,
Functional Outcomes(tgid=23) ⓘ
cardioP↑, 1, hepatoP↑, 1, memory↑, 1, neuroP↑, 1,
Total Targets: 25
Scientific Paper Hit Count for: Akt, PKB-Protein kinase B
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:4 State#:% Dir#:4
wNotes=0 sortOrder:rid,rpid
Home Page